CS logo
small CS logo
Klinikum Würzburg Mitte gGmbH Standort Missioklinik

Wurzburg, Germany
Hospital in Würzburg, Bavaria
Salvatorstraße 7, 97074 Würzburg

About Klinikum Würzburg Mitte gGmbH Standort Missioklinik


"Missioklinik und Juliusspital bilden gemeinsam das Klinikum Würzburg Mitte, ein modernes Klinikum mit zwei traditionsreichen Standorten. Als Krankenhaus der Schwerpunktversorgung bietet das KWM ein umfassendes medizinisches Behandlungsspektrum. Die mehr als 2.200 Mitarbeiter*innen des KWM versorgen jährlich etwa 30.000 Patienten."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Actelion
4
United Therapeutics
2
Hoffmann-La Roche
1
Total Rows: 3

Clinical Trials at Klinikum Würzburg Mitte gGmbH Standort Missioklinik


During the past decade, Klinikum Würzburg Mitte gGmbH Standort Missioklinik conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11112200110000001100Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
2012-06-26
2018-06-24
Completed
690
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
2013-09-11
2021-08-12
Completed
471
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2017-07-11
2021-03-12
Completed
143
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
2018-05-30
2023-05-30
Active, not recruiting
359
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
2019-01-23
2022-06-07
Terminated
131
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
2021-02-26
2024-09-15
Active, not recruiting
10

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsActelion: 4Actelion: 4United Therapeutics: 2United Therapeutics: 2Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinikum Würzburg Mitte gGmbH Standort Missioklinik


According to Clinical.Site data, the most researched conditions in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are "Pulmonary Arterial Hypertension" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Würzburg Mitte gGmbH Standort Missioklinik


Most popular intervention types in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Selexipag" (2 trials), "Atezolizumab" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Würzburg Mitte gGmbH Standort Missioklinik


The vast majority of trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are 7 trials for "All" genders.

Clinical Trials Status at Klinikum Würzburg Mitte gGmbH Standort Missioklinik


Currently, there are NaN active trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinikum Würzburg Mitte gGmbH Standort Missioklinik, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Würzburg Mitte gGmbH Standort Missioklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Completed: 3Completed: 3Terminated: 1Terminated: 1